Literature DB >> 10893675

Cellular localization of neprilysin in mouse bone tissue and putative role in hydrolysis of osteogenic peptides.

A F Ruchon1, M Marcinkiewicz, K Ellefsen, A Basak, J Aubin, P Crine, G Boileau.   

Abstract

The regulation of osteoblast and osteoclast metabolism is mediated by both hormones and local bone peptide factors. Peptides and hormones are under control of membrane peptidases such as Neprilysin (NEP). NEP is a widely distributed cell-surface zinc-metallopeptidase that is involved in the regulation of several important physiological processes by controlling the half-life of bioactive peptides. Although NEP is known to be present in skeletal tissues, neither its cellular localization nor its function have been established. To address this question, we examined NEP distribution in bones of postnatal mouse. In situ hybridization (ISH) and immunohistochemistry showed that NEP messenger RNA (mRNA) and protein are associated with bone-forming cells including presumptive osteoblast precursors, preosteoblasts, osteoblasts, and osteocytes. NEP levels in newborn and adult mice bones also were compared by immunoblotting. Higher amounts of NEP immunoreactivity were observed in newborn as compared with adult bones, suggesting a relationship between NEP expression and bone growth. To further explore this hypothesis, we monitored in vitro NEP proteolytic activity using a series of synthetic osteogenic peptides such as parathyroid hormone-related peptide 1-43 (PTHrP1-34), osteostatin (PTHrP107-139), osteogenic growth peptide (OGP), calcitonin, alpha-calcitonin gene-related peptide (alpha-CGRP), and PTH1-34. Except for PTH1-34, all peptides were found to be NEP substrates.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10893675     DOI: 10.1359/jbmr.2000.15.7.1266

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  11 in total

1.  Matrix metalloproteinase processing of PTHrP yields a selective regulator of osteogenesis, PTHrP1-17.

Authors:  J S Frieling; G Shay; V Izumi; S T Aherne; R G Saul; M Budzevich; J Koomen; C C Lynch
Journal:  Oncogene       Date:  2017-04-03       Impact factor: 9.867

2.  Surface plasmon resonance (SPR) confirms that MEPE binds to PHEX via the MEPE-ASARM motif: a model for impaired mineralization in X-linked rickets (HYP).

Authors:  Peter S N Rowe; Ian R Garrett; Patricia M Schwarz; David L Carnes; Eileen M Lafer; Gregory R Mundy; Gloria E Gutierrez
Journal:  Bone       Date:  2004-11-24       Impact factor: 4.398

Review 3.  Matrix vesicles: Are they anchored exosomes?

Authors:  Irving M Shapiro; William J Landis; Makarand V Risbud
Journal:  Bone       Date:  2015-05-15       Impact factor: 4.398

Review 4.  The wrickkened pathways of FGF23, MEPE and PHEX.

Authors:  Peter S N Rowe
Journal:  Crit Rev Oral Biol Med       Date:  2004-09-01

5.  Endothelin-converting enzyme-like 1 (ECEL1) is present both in the plasma membrane and in the endoplasmic reticulum.

Authors:  Alexandre Benoit; Miguel Angel Vargas; Luc Desgroseillers; Guy Boileau
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

6.  Chronic infantile neurological cutaneous articular syndrome: CD10 over-expression in neutrophils is a possible key to the pathogenesis of the disease.

Authors:  Valentina Leone; Gianni Presani; Sandra Perticarari; Alberto Tommasini; Sergio Crovella; Alessandro Lenhardt; Paolo Picco; Loredana Lepore
Journal:  Eur J Pediatr       Date:  2003-08-20       Impact factor: 3.183

7.  Osteostatin potentiates the bioactivity of mesoporous glass scaffolds containing Zn2+ ions in human mesenchymal stem cells.

Authors:  C Heras; S Sanchez-Salcedo; D Lozano; J Peña; P Esbrit; M Vallet-Regi; A J Salinas
Journal:  Acta Biomater       Date:  2019-03-16       Impact factor: 8.947

8.  Effects of thromboprophylaxis on mesenchymal stromal cells during osteogenic differentiation: an in-vitro study comparing enoxaparin with rivaroxaban.

Authors:  Hakan Pilge; Julia Fröbel; Silvia J Mrotzek; Johannes C Fischer; Peter M Prodinger; Christoph Zilkens; Bernd Bittersohl; Rüdiger Krauspe
Journal:  BMC Musculoskelet Disord       Date:  2016-03-01       Impact factor: 2.362

Review 9.  Proteolytic Regulation of Parathyroid Hormone-Related Protein: Functional Implications for Skeletal Malignancy.

Authors:  Jeremy S Frieling; Conor C Lynch
Journal:  Int J Mol Sci       Date:  2019-06-08       Impact factor: 5.923

Review 10.  New insights into the roles of metalloproteinases in neurodegeneration and neuroprotection.

Authors:  A J Turner; N N Nalivaeva
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.